The TARGET-CTCA Trial
Troponin in Acute chest pain to Risk stratify and Guide EffecTive use of Computed Tomography Coronary Angiography
TARGET-CTCA is a prospective, randomised, open label with blinded endpoint evaluation (PROBE) trial of CTCA in the diagnosis and management of patients who attend hospital with acute chest pain and intermediate high-sensitivity cardiac troponin concentrations.
About the Trial
TARGET-CTCA is a non-commercial trial sponsored by a partnership of the University of Edinburgh and NHS Lothian called ACCORD and funded by the British Heart Foundation (BHF).